Get ready for a potential game-changer in the fight against obesity! The future of weight-loss medication might be as simple as swallowing a pill. Experts are diving deep into the next generation of anti-obesity drugs, and oral GLP-1 medications are leading the charge. But here's where it gets controversial... will they be as effective as injectables, and what are the potential side effects?
Join leading endocrinologists as they explore these groundbreaking advancements at the upcoming Virtual Science Writers Conference on December 10th. Hosted by the Endocrine Society, this conference promises to be a crucial discussion for anyone following the latest breakthroughs in metabolic health.
What's on the Agenda?
The conference will focus on:
- The Rise of Oral GLP-1s: A thorough examination of pill-based GLP-1 receptor agonists – the first of their kind! These medications mimic a natural hormone in your body, helping to regulate blood sugar and appetite. This could revolutionize treatment, making it more accessible and convenient for patients. Think about it: no more needles! But, and this is the part most people miss, the bioavailability (how much of the drug your body actually uses) differs significantly between oral and injectable forms. Will the convenience outweigh potential dosage adjustments?
- Dual and Triple Agonists: The Power of Combination: Discover the science behind medications that target multiple hormone receptors simultaneously. By activating several pathways in the body, these drugs aim to achieve even greater weight loss and metabolic benefits. Imagine a single medication tackling multiple aspects of metabolic dysfunction! Current research is exploring combinations that could target glucose control, appetite, and even energy expenditure.
Who are the Experts?
Gain valuable insights from:
- Priya Jaisinghani, M.D., D.A.B.O.M.: A Clinical Assistant Professor at NYU Langone in New York, N.Y., Dr. Jaisinghani brings extensive clinical experience to the discussion. Her expertise in obesity medicine will be invaluable in understanding the practical implications of these new medications.
- Mehmet Furkan Burak, M.D.: Dr. Burak, from Brigham and Women’s Hospital and Harvard Medical School in Boston, Mass., is at the forefront of endocrine research. His academic background will shed light on the scientific mechanisms driving these innovative therapies.
When and Where?
Mark your calendars! The Virtual Science Writers Conference takes place on:
- Date: Wednesday, December 10th
- Time: 11:00 AM Eastern Time
How to Attend:
Secure your spot by registering for the conference here: https://endocrine-org.zoom.us/webinar/register/WNd-irWZW-SzK2PF-tuHX8w#/registration. Don't worry if you can't make it live – a recording will be available on the Endocrine Society’s YouTube channel.
Important Note: This event is supported by Eli Lilly.
About the Endocrine Society
The Endocrine Society is a leading global organization dedicated to hormone research and the care of individuals with hormone-related conditions. With over 18,000 members across 133 countries, the Society plays a vital role in advancing scientific knowledge, promoting clinical excellence, and advocating for evidence-based policies. Their work is crucial for tackling pressing health challenges like diabetes, obesity, infertility, bone health, and hormone-related cancers. Learn more at their online newsroom: https://www.endocrine.org/news-and-advocacy/news-room.
What are your thoughts on oral GLP-1s? Do you think they will eventually replace injectable medications? Are you concerned about potential side effects or the influence of pharmaceutical companies in these discussions? Share your opinions in the comments below!
